Subcutaneous 5-azacitidine treatment of naturally occurring canine urothelial carcinoma: a novel epigenetic approach to human urothelial carcinoma drug development.
about
Physiological and pathological implications of 5-hydroxymethylcytosine in diseasesDNA demethylation and invasive cancer: implications for therapeuticsMolecular targets in urothelial cancer: detection, treatment, and animal models of bladder cancerNaturally Occurring Canine Invasive Urinary Bladder Cancer: A Complementary Animal Model to Improve the Success Rate in Human Clinical Trials of New Cancer Drugs.6-Thioguanine and zebularine down-regulate DNMT1 and globally demethylate canine malignant lymphoid cells.Comparative Gene Expression Analyses Identify Luminal and Basal Subtypes of Canine Invasive Urothelial Carcinoma That Mimic Patterns in Human Invasive Bladder Cancer.Epigenetic alterations in bladder cancer and their potential clinical implications.5-Azacytidine treatment induces demethylation of DAPK1 and MGMT genes and inhibits growth in canine mammary gland tumor cells.Targeting DNA Methyltranferases in Urological Tumors.
P2860
Q26749375-FF634259-3FC4-489B-B4C9-7B9128124DEDQ27011914-1B04F858-3D63-4A95-AEC3-7EF2AD8577F5Q28076041-0DA8A107-3DB1-491F-99E3-3AF9FB486A75Q33593041-8948CE21-D9AF-4384-B0D8-CF7D39B9E251Q34748281-5EAD9F8A-7EB6-4758-AE67-AFC3C0E3CE2FQ35767570-3550DFB6-B29F-48D4-9616-73C2ABC661C4Q36095721-84B1DB67-81E1-4C36-9676-06D46F103AFEQ55379064-40444F92-F9A9-48E7-B44C-4D145B34C4F5Q55435258-8A88766E-BF8A-4585-ADA4-40165F307DFA
P2860
Subcutaneous 5-azacitidine treatment of naturally occurring canine urothelial carcinoma: a novel epigenetic approach to human urothelial carcinoma drug development.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Subcutaneous 5-azacitidine tre ...... al carcinoma drug development.
@ast
Subcutaneous 5-azacitidine tre ...... al carcinoma drug development.
@en
type
label
Subcutaneous 5-azacitidine tre ...... al carcinoma drug development.
@ast
Subcutaneous 5-azacitidine tre ...... al carcinoma drug development.
@en
prefLabel
Subcutaneous 5-azacitidine tre ...... al carcinoma drug development.
@ast
Subcutaneous 5-azacitidine tre ...... al carcinoma drug development.
@en
P2093
P2860
P1476
Subcutaneous 5-azacitidine tre ...... al carcinoma drug development.
@en
P2093
Corie Hartman-Frey
Curtis Balch
David R Jones
Deborah W Knapp
Deepika Dhawan
Erika M Kwon
Heidi G Parker
Kenneth P Nephew
Noah M Hahn
P2860
P304
P356
10.1016/J.JURO.2011.09.010
P407
P577
2011-11-17T00:00:00Z